Related Experiment Video
Updated: Jun 12, 2026

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
Published on: November 1, 2017
Strongly ROS-Correlated, Time-Dependent, and Selective Antiproliferative Effects of Synthesized Nano Vesicles on BRAF
Silvana Alfei1, Guendalina Zuccari1,2, Constantinos M Athanassopoulos3
1Department of Pharmacy, University of Genoa, Viale Cembrano, 16148 Genoa, Italy.
Abstract:
Cutaneous metastatic melanoma (CMM) is the most aggressive form of skin cancer with a poor prognosis. Drug-induced secondary tumorigenesis and the emergency of drug resistance worsen an already worrying scenario, thus rendering urgent the development of new treatments not dealing with mutable cellular processes. Triphenyl phosphonium salts (TPPSs), in addiction to acting as cytoplasmic membrane disruptors, are reported to be mitochondria-targeting compounds, exerting anticancer effects mainly by damaging their membranes and causing depolarization, impairing mitochondria functions and their DNA, triggering oxidative stress (OS), and priming primarily apoptotic cell death. TPP-based bola amphiphiles are capable of self-forming nanoparticles (NPs) with enhanced biological properties, as commonly observed for nanomaterials. Already employed in several other biomedical applications, the per se selective potent antibacterial effects of a TPP bola amphiphile have only recently been demonstrated on 50 multidrug resistant (MDR) clinical superbugs, as well as its exceptional and selective anticancer properties on sensitive and MDR neuroblastoma cells. Here, aiming at finding new molecules possibly developable as new treatments for counteracting CMM, the effects of this TPP-based bola amphiphile (BPPB) have been investigated against two BRAF mutants CMM cell lines (MeOV and MeTRAV) with excellent results (even IC50 = 49 nM on MeOV after 72 h treatment). With these findings and considering the low cytotoxicity of BPPB against different mammalian non-tumoral cell lines and red blood cells (RBCs, selectivity indexes up to 299 on MeOV after 72 h treatment), the possible future development of BPPB as topical treatment for CMM lesions was presumed. With this aim, a biodegradable hyaluronic acid (HA)-based hydrogel formulation (HA-BPPB-HG) was prepared without using any potentially toxic crosslinking agents simply by dispersing suitable amounts of the two ingredients in water and sonicating under gentle heating. HA-BPPB-HA was completely characterized, with promising outcomes such as high swelling capability, high porosity, and viscous elastic rheological behavior.
Insights
Triphenyl phosphonium salts (TPPSs) show potent anticancer effects against cutaneous metastatic melanoma (CMM) by targeting mitochondria. A novel TPP-based bola amphiphile (BPPB) formulated in a hyaluronic acid hydrogel offers a promising topical treatment for CMM.
Area of Science:
- Biochemistry
- Materials Science
- Oncology
Background:
- Cutaneous metastatic melanoma (CMM) is an aggressive skin cancer with poor prognosis.
- Drug resistance and secondary tumorigenesis necessitate novel therapeutic strategies.
- Triphenyl phosphonium salts (TPPSs) target mitochondria, inducing cell death and oxidative stress.
Purpose of the Study:
- To investigate the efficacy of a TPP-based bola amphiphile (BPPB) against CMM cell lines.
- To evaluate the potential of BPPB as a topical treatment for CMM.
- To develop a safe and effective hydrogel formulation for BPPB delivery.
Main Methods:
- Investigated BPPB effects on BRAF-mutant CMM cell lines (MeOV, MeTRAV).
- Assessed BPPB cytotoxicity against non-tumoral cell lines and red blood cells (RBCs).
- Formulated a hyaluronic acid (HA)-based hydrogel (HA-BPPB-HG) for BPPB delivery.
Main Results:
- BPPB demonstrated excellent anticancer activity against CMM cells, with IC50 values as low as 49 nM.
- BPPB exhibited low cytotoxicity towards non-tumoral cells and RBCs, indicating high selectivity (selectivity index up to 299).
- The HA-BPPB-HG formulation showed promising characteristics, including high swelling, porosity, and suitable rheological behavior.
Conclusions:
- BPPB is a potent agent against CMM, targeting mitochondria and exhibiting high selectivity.
- The HA-BPPB-HG hydrogel offers a viable platform for topical CMM treatment.
- Further development of BPPB holds promise for a new therapeutic approach to CMM.
More Related Videos
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
10:49Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
Published on: June 16, 2022